These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3477470)

  • 1. 1 alpha(OH)D3 (ETALPHA) treatment and receptor studies in 16 patients with chronic and myeloproliferative disorders.
    Wieslander SB; Mortensen BT; Binderup L; Nissen NI
    Eur J Haematol; 1987 Jul; 39(1):35-8. PubMed ID: 3477470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific cytosol receptors for 1,25-dihydroxyvitamin D3 in human intestine.
    Wecksler WR; Mason RS; Norman AW
    J Clin Endocrinol Metab; 1979 Apr; 48(4):715-7. PubMed ID: 429514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.
    Honma Y; Hozumi M; Abe E; Konno K; Fukushima M; Hata S; Nishii Y; DeLuca HF; Suda T
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):201-4. PubMed ID: 6296868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis.
    Brandi L; Daugaard H; Tvedegaard E; Storm T; Olgaard K
    Nephron; 1989; 53(3):194-200. PubMed ID: 2797340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of combined 24,25(OH)2D3 and 1 alpha (OH)D3 therapy for bone disease in dialysis patients.
    Popovtzer MM; Levi J; Bar-Khayim Y; Shasha SM; Boner G; Bernheim J; Chaimovitz C; Rubinger D; Gafter U; Gazit D
    Bone; 1992; 13(5):369-77. PubMed ID: 1419378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS; Coburn JW; Friedman GR; Okamura WH; Massry SG; Norman AW
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW; Zhou JY; Henry HL; Uskokovic MR; Koeffler HP
    Cancer Res; 1990 Nov; 50(21):6857-64. PubMed ID: 2208153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.
    Mornière P; Maurouard C; Boudailliez B; Westeel PF; Achard JM; Boitte F; el Esper N; Compagnon M; Maurel G; Bouillon R
    Nephron; 1992; 60(2):154-63. PubMed ID: 1552999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L; Egfjord M; Olgaard K
    Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1 alpha(OH)D3 treatment and procollagen III (PC III) studies in idiopathic myelofibrosis.
    Tsatalas C; Curtoglou G; Fotopoulos D; Halkia P; Vyzantiadis AT; Sinakos Z
    Haematologica; 1989; 74(6):559-62. PubMed ID: 2628238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the toxicity of 1 alpha-hydroxyvitamin D3 and 24,25 (RS)-dihydroxyvitamin D3 in rats].
    Khaĭdakov MS; Alekseeva IA; Belakovskiĭ MS; Blazheevich NV; Spirichev VB
    Farmakol Toksikol; 1985; 48(4):106-9. PubMed ID: 3876239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
    Tsuchiya H; Morishita H; Tomita K; Ueda Y; Tanaka M
    J Orthop Res; 1993 Jan; 11(1):122-30. PubMed ID: 8423514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands.
    Brumbaugh PF; Hughes MR; Haussler MR
    Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4871-5. PubMed ID: 1061076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic effectiveness of vitamin D3 in patients with myelodysplastic syndromes, leukemias and myeloproliferative disorders].
    Takahashi T; Ichiba S; Okuno Y; Sugiyama H; Sakai Y; Imura H; Iho S; Hoshino T; Suzuki A; Okada T
    Rinsho Ketsueki; 1989 Jan; 30(1):1-10. PubMed ID: 2716194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of a 1,25-dihydroxycholecalciferol cytoplasmic receptor-like binder in mouse kidney.
    Colston KW; Feldman D
    J Clin Endocrinol Metab; 1979 Nov; 49(5):798-800. PubMed ID: 489720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone.
    Birkenhäger-Frenkel DH; Pols HA; Zeelenberg J; Eijgelsheim JJ; Schot R; Nigg AL; Weimar W; Mulder PG; Birkenhäger JC
    J Bone Miner Res; 1995 Feb; 10(2):197-204. PubMed ID: 7754799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Displacement potency of vitamin D2 analogs in competitive protein-binding assays for 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D3, and 1,25-dihydroxyvitamin D3.
    Jones G; Byrnes B; Palma F; Segev D; Mazur Y
    J Clin Endocrinol Metab; 1980 Apr; 50(4):773-5. PubMed ID: 6965943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of active vitamins D3, 1 alpha-hydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in patients on chronic hemodialysis.
    Kimura Y; Nakayama M; Kuriyama S; Watanabe S; Kawaguchi Y; Sakai O
    Clin Nephrol; 1991 Feb; 35(2):72-7. PubMed ID: 2019017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.